PMSNF (Proteome Sciences) Net Change in Cash: $0.43 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proteome Sciences Net Change in Cash?

Proteome Sciences PMSNF Net Change in Cash is $0.43 Mil as of Jun. 2026. The stock has 6 warning signs investors should review.

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Proteome Sciences's Net Change in Cash for the six months ended in Jun. 2026 was $0.43 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 was $0.43 Mil.

Proteome Sciences Net Change in Cash Historical Data

* Premium members only.

The historical data trend for Proteome Sciences's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteome Sciences Net Change in Cash Chart

Proteome Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 1.98 -2.45 -1.15 -0.46

Proteome Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Jun26
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.21 -1.04 -0.12 -1.12 0.43

Proteome Sciences Net Change in Cash Calculation

Proteome Sciences's Net Change in Cash for the fiscal year that ended in Dec. 2025 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.06062295200067+-0.12783535530576+-0.26884961322037+
=-0.46

Proteome Sciences's Net Change in Cash for the quarter that ended in Jun. 2026

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.57303941086266+-0.022867769917054+0.78692031773393+0.23943900266092
=0.43

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Change in Cash →
What does a Net Change in Cash of $0.43 Mil mean?
Proteome Sciences (PMSNF) has a Net Change in Cash of $0.43 Mil as of Jun. 2026. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for Proteome Sciences and its competitors.
Is Proteome Sciences' Net Change in Cash too high?
Proteome Sciences' current Net Change in Cash is $0.43 Mil.
How does Proteome Sciences' Net Change in Cash compare to TMO and DHR?
Proteome Sciences' Net Change in Cash of $0.43 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Change in Cash for a Medical Diagnostics & Research company?
A good Net Change in Cash depends on the Medical Diagnostics & Research industry context. However, Net Change in Cash should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Change in Cash mean?
A high Net Change in Cash can signal that a stock is expensive relative to its fundamentals. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for Proteome Sciences and its competitors. Proteome Sciences's current Net Change in Cash is $0.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Based on GuruFocus' analysis, Proteome Sciences (PMSNF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.03, compared to a current price of $0.01 — trading 62.7% below its estimated fair value. The current Net Change in Cash is $0.43 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Change in Cash calculated?
Net Change in Cash is calculated from a company's financial statements. For Proteome Sciences (PMSNF), the current Net Change in Cash is $0.43 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proteome Sciences Business Description

Other Exchanges PRMl:UKPRM:UKPI2:Germany
Address Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is a UK-based contract research organization focused on protein biomarker discovery, validation, and application. The company provides research services to pharmaceutical, biotechnology, and academic customers, helping identify and quantify protein biomarkers for drug development, diagnostics, and clinical research. Its portfolio includes proprietary biomarker assays and mass spectrometry reagents, notably its TMT (Tandem Mass Tag) labelling reagents used in quantitative proteomics. Revenue comes from sales of goods, biomarker research services, and royalties tied to end-customer sales of products incorporating its technology. Proteome Sciences operates primarily in the United Kingdom, the United States, and the European Union, serving a global life sciences customer base. The company also holds intellectual property covering biomarker panels and related methods, licensing these to partners in the pharmaceutical and diagnostics industries.